Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Viciana

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|January 12, 2001
[Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)]J M Miró, A Antela, J Arrizabalaga, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 8, 2000
[Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)]J M Miró, A Antela, J Arrizabalaga, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 18, 2000
[The recommendations of GESIDA/SEFH/PNS for improving adherence to antiretroviral treatment. AIDS Study Group of the Spanish Society of Hospital Pharmacy and the National Plan on AIDS of the Minister of Health and Consumers]H Knobel, C Codina, J M Miró, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1996
Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus. Grupo Andaluz para el Estudio de las Enfermedades InfecciosasF Lozano, J Torre-Cisneros, A Bascuñana, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 20, 2008
Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART statusS Moreno, I Jarrin, J A Iribarren, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2005
Once-daily antiretroviral therapy: Spanish Consensus StatementF Pulido, E Ribera, S Moreno, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
IFNL4 ss469415590 polymorphism is associated with unfavourable clinical and immunological status in HIV-infected individualsK Machmach, C Abad-Molina, M C Romero-Sánchez, et al.
HIV Medicine|September 30, 2009
The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patientsI Suarez-Lozano, P Viciana, J-R Lacalle, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2007
Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in SpainM Diez, A Diaz, M J Bleda, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2014
Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patientsD Podzamczer, A Imaz, I Perez, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Enfermedades Infecciosas Y Microbiologia Clinica|January 12, 2001
[Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)]J M Miró, A Antela, J Arrizabalaga, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 8, 2000
[Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)]J M Miró, A Antela, J Arrizabalaga, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 18, 2000
[The recommendations of GESIDA/SEFH/PNS for improving adherence to antiretroviral treatment. AIDS Study Group of the Spanish Society of Hospital Pharmacy and the National Plan on AIDS of the Minister of Health and Consumers]H Knobel, C Codina, J M Miró, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1996
Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus. Grupo Andaluz para el Estudio de las Enfermedades InfecciosasF Lozano, J Torre-Cisneros, A Bascuñana, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 20, 2008
Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART statusS Moreno, I Jarrin, J A Iribarren, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2005
Once-daily antiretroviral therapy: Spanish Consensus StatementF Pulido, E Ribera, S Moreno, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
IFNL4 ss469415590 polymorphism is associated with unfavourable clinical and immunological status in HIV-infected individualsK Machmach, C Abad-Molina, M C Romero-Sánchez, et al.
HIV Medicine|September 30, 2009
The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patientsI Suarez-Lozano, P Viciana, J-R Lacalle, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2007
Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in SpainM Diez, A Diaz, M J Bleda, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2014
Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patientsD Podzamczer, A Imaz, I Perez, et al.
Pageof 8